Literature DB >> 29653207

Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform.

Christopher G Kanakry1, Leo Luznik2.   

Abstract

Entities:  

Keywords:  BMT; Graft-versus-host disease; Haploidentical; Post-transplantation cyclophosphamide; Transplantation

Mesh：

Substances：

Year:  2018        PMID： 29653207     DOI： 10.1016/j.bbmt.2018.04.004

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  4 in total

1.  Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.

Authors:  Mi Kwon; Rebeca Bailén; María Jesús Pascual-Cascón; Ana Isabel Gallardo-Morillo; Abel García Sola; Pascual Balsalobre; Laura Solán; Nieves Dorado; Cristina Muñoz; David Serrano; Carolina Martínez-Laperche; Ismael Buño; Javier Anguita; José Luis Díez-Martin
Journal:  Blood Adv       Date:  2019-11-12

2.  Optimized Timing of Post-Transplantation Cyclophosphamide in MHC-Haploidentical Murine Hematopoietic Cell Transplantation.

Authors:  Lucas P Wachsmuth; Michael T Patterson; Michael A Eckhaus; David J Venzon; Christopher G Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-10-02       Impact factor: 5.742

3.  Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.

Authors:  Lucas P Wachsmuth; Michael T Patterson; Michael A Eckhaus; David J Venzon; Ronald E Gress; Christopher G Kanakry
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 19.456

Review 4.  Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding.

Authors:  Natalia S Nunes; Christopher G Kanakry
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.